Exploring the Antimicrobial, Anticancer, and Apoptosis Inducing Ability of Biofabricated Silver Nanoparticles Using Flower Buds Against the Human Osteosarcoma (MG-63) Cell Line Via Flow Cytometry
Overview
Authors
Affiliations
Biosynthesized nano-composites, such as silver nanoparticles (AgNPs), can be engineered to function as smart nano-biomedicine platforms for the detection and management of diverse ailments, such as infectious diseases and cancer. This study determined the eco-friendly fabrication of silver nanoparticles using (L.) Pers. flower buds and their efficacy against antimicrobial and anticancer activities. The UV-Visible spectrum was found at 413 nm showing a typical resonance spectrum for flower bud extract-assisted silver nanoparticles (Ls-AgNPs). Fourier transform infrared analysis revealed the presence of amines, halides, and halogen compounds, which were involved in the reduction and capping agent of AgNP formation. X-ray diffraction analysis revealed the face-centered cubic crystals of NPs. Energy dispersive X-ray verified the weight of 39.80% of silver (Ag), TEM analysis revealed the particles were spherical with a 10.27 to 62.5 nm range, and dynamic light scattering recorded the average particle size around 58.5 nm. Zeta potential showed a significant value at -39.4 mV, and finally, thermo-gravimetric analysis reported higher thermal stability of Ls-AgNPs. Further, the obtained Ls-AgNPs displayed good antimicrobial activity against clinical pathogens. In addition, a dose-dependent decrease in the anticancer activity by MTT assay on the osteosarcoma (MG-63) cell line showed a decrease in the cell viability with increasing in the concentration of Ls-AgNPs with an IC value of 37.57 µg/mL. Subsequently, an apoptotic/necrosis study was conducted with the help of Annexin-V/PI assay, and the results indicated a significant rise in early and late apoptosis cell populations. Therefore, green synthesized Ls-AgNPs were found to have potent antimicrobial and anticancer properties making them fascinating choices for future bio-medical implementations.
Aati S, Aati H, Hamed A, El-Shamy S, Aati S, Abdelmohsen U RSC Adv. 2025; 15(5):3954-3968.
PMID: 39917041 PMC: 11799888. DOI: 10.1039/d4ra07608g.
Wehbe N, Mesmar J, El Kurdi R, Al-Sawalmih A, Badran A, Patra D Sci Rep. 2025; 15(1):4286.
PMID: 39905108 PMC: 11794841. DOI: 10.1038/s41598-024-81875-0.
Rajkumar M, Presley S, Govindaraj P, Kirubakaran D, Farahim F, Ali T Sci Rep. 2025; 15(1):3931.
PMID: 39890965 PMC: 11785806. DOI: 10.1038/s41598-025-87932-6.
Ashrafi-Saiedlou S, Rasouli-Sadaghiani M, Fattahi M, Ghosta Y Sci Rep. 2025; 15(1):1018.
PMID: 39762412 PMC: 11704013. DOI: 10.1038/s41598-024-84974-0.
Dadayya M, Thippeswamy M, Shivaiah N, Siddaraju T, Jayaramaiah P, Veeranna S Sci Rep. 2025; 15(1):606.
PMID: 39753586 PMC: 11698845. DOI: 10.1038/s41598-024-76475-x.